Brief: Bluejay Diagnostics, Inc. Announces Completion Of 624 Patient Enrollments In Symon-Ii Pivotal Clinical Trial
07/04/2026 11:56
April 7 (Reuters) - Bluejay Diagnostics Inc BJDX.O: BLUEJAY DIAGNOSTICS, INC. ANNOUNCES COMPLETION OF 624 PATIENT ENROLLMENTS IN SYMON-II PIVOTAL CLINICAL TRIAL Source text: ID:nGNX2s8zsq Further company coverage: BJDX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Bluejay Diagnostics
See all newsBrief: Bluejay Diagnostics Announces Successful Completion Of Enrollment In The Symon-II Multicenter Clinical Validation Study
Brief: Bluejay Diagnostics And Argonaut Manufacturing Services Announce Strategic Partnership
Bluejay Diagnostics Q1 net loss unchanged
Brief: Bluejay Diagnostics, Inc. Announces Completion Of 624 Patient Enrollments In Symon-Ii Pivotal Clinical Trial
Brief: Bluejay Diagnostics Provides Corporate Update And 2026 Strategic Outlook